athenahealth and Tandigm Health Partner on Population Health Initiatives
/
Date20 Oct 2016
WATERTOWN, Mass. and CONSHOHOCKEN, Pa., Oct. 20, 2016 (GLOBE NEWSWIRE) — athenahealth, Inc. (NASDAQ:ATHN), a leading provider of network-enabled services and mobile applications for healthcare... Read More →
TMG Health To Sponsor and Exhibit at AHIP National Conferences on Medicare, Medicaid & Duals October 23-27
/
Date20 Oct 2016
CONSHOHOCKEN, PA., Oct. 20, 2016 (GLOBE NEWSWIRE) — TMG Health, the leading national provider of Business Process Outsourcing solutions for Health Plans in the Medicare... Read More →
Citizens Commission on Human Rights Calling for Ban on Use of Brain Damaging ECT
/
Date20 Oct 2016
CLEARWATER, Fla., Oct. 20, 2016 (GLOBE NEWSWIRE) — The Citizens Commission on Human Rights (CCHR), a non-profit mental health watchdog supported by the Church of... Read More →
Steadman Hawkins Clinic-Denver Joins UCHealth and CU to Grow Sports Performance Medicine and Orthopedic Program
/
Date20 Oct 2016
AURORA, Colo., Oct. 20, 2016 (GLOBE NEWSWIRE) — Patients throughout the Rocky Mountain region will soon have access to new sports performance and advanced orthopedic... Read More →
Madrigal Pharmaceuticals Announces the Initiation of a Phase 2 Study of MGL-3196 in Patients with Non-alcoholic Steatohepatitis (NASH)
/
Date20 Oct 2016
— Study expected to provide proof-of-concept data in NASH for the first liver-directed, thyroid hormone receptor (THR) ß-selective agonist – — Primary endpoint is the... Read More →
Pacira Pharmaceuticals Continues to Build Out Robust Commercial Leadership Team
/
Date20 Oct 2016
PARSIPPANY, N.J., Oct. 20, 2016 (GLOBE NEWSWIRE) — Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced the appointment of two key individuals who will assume leadership roles... Read More →
Selecta Biosciences Presented Preclinical Data Applying SVP-Rapamycin in Gene Therapy at Annual Congress of the European Society of Gene and Cell Therapy
/
Date20 Oct 2016
Data underscore potential of SVP-Rapamycin to enhance therapeutic benefit of gene therapies by mitigating unwanted humoral (antibody) and cellular immune responses WATERTOWN, Mass., Oct. 20,... Read More →
Spark Therapeutics Announces Collaboration with Leading Gene Therapy Center at University of Massachusetts Medical School
/
Date20 Oct 2016
PHILADELPHIA, Oct. 20, 2016 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company seeking to transform the lives of patients with debilitating... Read More →
RadioMedix Inc. successfully completed the Phase I/ II clinical studies for AminoMedix ™ used for radiation kidney protection during Peptide-Receptor Radionuclide Therapy (PRRT)
/
Date20 Oct 2016
Houston, TX, Oct. 20, 2016 (GLOBE NEWSWIRE) — RadioMedix Inc. (Houston,TX) is excited to announce the completion of the Phase I/II clinical trial of AminoMedix... Read More →
ABLYNX OUTLINES NEXT STEPS FOR ITS ANTI-IL-6R NANOBODY, VOBARILIZUMAB, A POTENTIAL BEST-IN-CLASS TREATMENT FOR RHEUMATOID ARTHRITIS
/
Date20 Oct 2016
AbbVie has decided at this time not to exercise its right to opt-in and license vobarilizumab in RA Additional analysis of the Phase IIb RA... Read More →